The 17β-HSD (17β-hydroxysteroid dehydrogenase) from the filamentous fungus Cochliobolus lunatus (17β-HSDcl) is a NADP(H)-dependent enzyme that preferentially catalyses the interconversion of inactive 17-oxo-steroids and their active 17β-hydroxy counterparts. 17β-HSDcl belongs to the SDR (shortchain dehydrogenase/reductase) superfamily. It is currently the only fungal 17β-HSD member that has been described and represents one of the model enzymes of the cP1 classical subfamily of NADPH-dependent SDR enzymes. A thorough crystallographic analysis has been performed to better understand the structural aspects of this subfamily and provide insights into the evolution of the HSD enzymes. The crystal structures of the 17β-HSDcl apo, holo and coumestrol-inhibited ternary complex, and the active-site Y167F mutant reveal subtle conformational differences in the substrate-binding loop that probably modulate the catalytic activity of 17β-HSDcl. Coumestrol, a plant-derived non-steroidal compound with oestrogenic activity, inhibits 17β-HSDcl [IC 50 2.8 μM; at 100 μM substrate (4-oestrene-3,17-dione)] by occupying the putative steroid-binding site. In addition to an extensive hydrogen-bonding network, coumestrol binding is stabilized further by π-π stacking interactions with Tyr 212 . A stopped-flow kinetic experiment clearly showed the coenzyme dissociation as the slowest step of the reaction and, in addition to the low steroid solubility, it prevents the accumulation of enzyme-coenzyme-steroid ternary complexes.
INTRODUCTION
17β-HSDs (17β-hydroxysteroid dehydrogenases) are enzymes that are involved in the metabolism of hormonally active steroids. By catalysing the final step of steroid biosynthesis, 17β-HSDs act as regulators of steroid hormone activities at the prereceptor level [1] [2] [3] . Indeed, 17β-HSDs modulate the potencies of the androgens and oestrogens by stereo-specifically reducing the less active 17-oxo-steroids into the more active 17β-hydroxy forms that have high affinities for their corresponding receptors, or vice versa ( Figure 1A ). 17β-HSDs are widespread among all organisms; they have been found in bacteria and fungi [4] , whereas 14 different forms have been isolated in vertebrates [5] . In humans, 12 different isoforms have been reported to date [5, 6] , which differ in their tissue localizations and physiological functions. The 17β-HSDs have been related to several human pathologies [7] , including polycystic kidney diseases, pseudohermaphroditism, various hormone-dependent forms of cancer (e.g. breast or prostate) and Alzheimer's disease. In microorganisms, the functions of the 17β-HSDs are less clear, and they are often associated with detoxification pathways [4, 8] .
17β-HSDs all require NAD(P)(H) as a coenzyme and, with only one exception, they all belong to the SDR (short-chain dehydrogenase/reductase) protein superfamily [9, 10] . The SDR enzymes have a molecular mass of 23-35 kDa; they are functional as oligomers (generally as dimers or tetramers) and have a common protein fold (the Rossmann fold) [11] . NADP(H)-dependent SDR enzymes have one or two positively charged residues that compensate for the two negative charges of the 2 -phosphate group of the coenzyme, whereas NAD(H)-dependent enzymes have an acidic residue that electrostatically repels NADP(H) as the key determining factor for the NAD(H) preference. The directional preference of the SDR enzymes is thus governed mainly by affinities for coenzymes [NADP(H) compared with NAD(H)] and by the concentration ratios between their reduced and the oxidized forms [12] .
A constitutive 17β-HSD has been isolated and purified from the filamentous fungus Cochliobolus lunatus (17β-HSDcl) [13] , an occasional plant and human pathogen with some potential in biotechnological applications (see [14] and references therein). 17β-HSDcl represents the first fully characterized fungal 17β-HSD; it was cloned and overexpressed in Escherichia coli [15] , and extensive studies have been carried out on its biochemical and kinetic behaviours [16] [17] [18] [19] . It is a cytosolic enzyme with a molecular mass of 28 kDa, it requires NADP(H) as a coenzyme and shows in vitro catalytic activity in both the oxidative and reductive directions [13] . 17β-HSDcl is fully functional as a dimer and shows an optimum pH of 7-8 for the interconversions of 4-oestrene-3,17-dione and 4-oestrene-17β-ol-3-one [15] .
Substrate specificity studies revealed that 4-oestrene-3,17-dione and 4-oestrene-17β-ol-3-one is the best substrate pair, followed by 5α-androstane-3,17-dione/5α-androstane-17β-ol-3-one and 4-androstene-3,17-dione/4-androstene-17β-ol-3-one, whereas oestrone and oestradiol are less preferred substrates [20] . These steroids revealed no substrate inhibition at concentrations up to 200 μM (T. Lanišnik Rižner, K. Kristan and M. Brunskolě Segel; unpublished work). To date, steroids are still the best known substrates of this enzyme, and our recent data show also that phenathrenequinone, a classical substrate of carbonyl reductases, is very poorly converted by 17β-HSDcl [21] .
Analysis of the 17β-HSDcl amino acid sequence shows the presence of the characteristic sequence motifs of the SDR superfamily: the TG 25 [15, 22] . 17β-HSDcl is an NADP(H)-dependent enzyme [18] and belongs to the cP1 classical subfamily of the SDRs [23] in which the two negative charges of the 2 -phosphate group of the coenzyme are compensated for by only one basic residue, Arg 28 , in the coenzyme-binding motif [19] . The amino acid sequence is highly similar to those of several fungal carbonyl reductases and also to SDR members (see Supplementary Figure S1 at http://www.BiochemJ.org/bj/441/bj4410151add.htm for a sequence alignment) involved in the biosynthesis of mycotoxins, aflatoxins, sterigmatocystin and the fungal pigment melanin: versicolorin reductase from Aspergillus parasiticus (67 % identity) and Emericella nidulans (65 %); and 3HNR (1,3,8-trihydroxynaphthalene reductase) from Colletotrichum lagenarium (61 %) and Magnaporthe grisea (3HNRmg) (58 %). Among the HSDs, the highest similarity has been shown for the E. coli 7α-HSD (37 % identity), Brucella melitensis 7α-HSD (31 %), human 17β-HSD type 4 (31 %) and various mammalian 17β-HSDs type 8 (Mus musculus 30 %, Rattus norvegicus 29 %, Canis familiaris 29 %, Sus scrofa 28 % and Homo sapiens 28 %) [15] .
Despite the high amino acid similarity between 17β-HSDcl and 3HNR, these two enzymes have distinct roles and functions [24, 25] . A participation of 17β-HSDcl in fungal secondary metabolism has been suggested [26] , although its physiological role is currently not known. The characterization of a recently prepared C. lunatus knockout (N. Kraševec and T. Lanišnik Rižner, unpublished work) should soon lead to the determination of its function. 17β-HSDcl was the subject of a thorough kinetics analysis, which proposed an ordered Bi Bi reaction mechanism of the Theorell-Chance type [17] . To improve further our understanding of the catalytic events at the molecular level, as well as evolution of HSDs, in the present study, we have conducted a comprehensive structural analysis of 17β-HSDcl. We have solved the crystal structure of the apoenzyme, its active-site mutant Y167F, the functionally active NADPH binary complex and a ternary complex with coumestrol, an inhibitor with an IC 50 of 2.8 μM that provides insights into the structural determinants crucial for the binding of steroid substrates [27] . Additionally, two kinetic experiments were performed, with the focus on the accumulated reaction intermediates and the identification of the limiting step of the reaction rate.
EXPERIMENTAL
Expression and purification of recombinant 17β-HSDcl 17β-HSDcl was prepared as a GST (glutathione transferase)-fusion protein in E. coli JM107 cells. Protein purification, including GST-tag cleavage by thrombin, was carried out as described previously [15] . Protein concentrations were determined using the method of Bradford [28] with BSA as standard. The purity of the protein was checked by SDS/PAGE on 12 % polyacrylamide gels with Coomassie Blue staining [29] .
Initial rate measurements of 17β-HSDcl activity in both directions
Oxidation of 4-oestrene-17β-ol-3-one in the presence of NADP + and reduction of 4-oestrene-3,17-dione in the presence of NADPH were monitored using a PerkinElmer Lambda 45 UV-visible spectrophotometer. The differences in NADPH absorbance were measured for 600 s at 340 nm and 25
• C. The assays were carried out in 0.6 ml of 100 mM phosphate buffer (pH 8.0), with a 1 % final concentration of N,N-dimethylformamide as co-solvent. An array of the time courses of the enzymatic reactions was measured at seven substrate and seven coenzyme concentrations, both ranging from 20 to 140 μM, in the presence of 0.5 μM 17β-HSDcl.
Measuring the first turnover in the 17β-HSDcl reaction with NADP + and 4-oestrene-17β-ol-3-one
The first turnover of the 4-oestrene-17β-ol-3-one by the 17β-HSDcl-NADP + complex was measured on a SF/PQ-53 stoppedflow apparatus (Hi-Tech Scientific). Aliquots (150 μl) of two solutions, one containing 800 μM NADP + and 9.2 μM 17β-HSDcl, and the other containing 300 μM substrate 4-oestrene-17β-ol-3-one, were mixed at a volume ratio of 1:1 in the mixing chamber of the stopped-flow apparatus. The difference in NADPH absorbance was measured in a split run for 10 s and for the next 200 s, at 25
• C in 100 mM phosphate buffer (pH 8.0), with a 1.5% final concentration of N,N-dimethylformamide as cosolvent. Analysis of the progress curves, measured in triplicate, was carried out by fitting the coefficients of the differential equations characteristic for the Theorell-Chance mechanism, to the experimental points. The reaction scheme was drawn on the web-server at http://enzo.cmm.ki.si/ and the progress curve data along with initial values of the rate constants were submitted for the analysis.
Crystallization and data collection
Crystals of the apo and Y167F mutant forms of 17β-HSDcl were obtained according to a protocol described previously [30] . Crystals of the triclinic holo form were obtained by using the hanging-drop vapour-diffusion method. In addition, crystals of the 17β-HSDcl holo form belonging to the monoclinic system were obtained in less than 1 week following the same protocol as described above with a precipitant solution composition of 30 % (w/v) PEG 2000 MME (monomethyl ether) and 0.1 M KCNS (pH 7.0). Monoclinic crystals of the holoenzyme were used for the inhibition studies. The crystals were soaked for 24 h in a solution with the following composition: 30 % (w/v) PEG 2000 MME, 0.1 M KCNS, 5 % (v/v) DMSO, 2 mM NADPH and 2 mM coumestrol.
A complete dataset from the native apo 17β-HSDcl crystal up to 1.5 Å (1 Å = 0.1 nm) resolution was acquired at the XRD1 beamline at ELETTRA synchrotron, following the same procedures for data collection and data reduction already described in our previous study [30] . A 1.9 Å dataset from the apo Y167F mutant crystal was collected at the ID 23-2 beamline at the ESRF (European Synchrotron Radiation Facility) synchrotron (X-ray wavelength of 0.8726 Å). A complete 1.9 Å dataset from a crystal of the holo triclinic crystal form was collected at the beamline ID 14-4 at the ESRF (X-ray wavelength of 0.939 Å). Finally, a dataset for the ternary complex was collected at the XRD1 beamline at ELETTRA up to a 2.5 Å resolution (X-ray wavelength of 1.0 Å) and using crystallization solution containing 15 % (v/v) ethylene glycol as a cryoprotectant. All datasets were collected at cryogenic temperature (100 K). All of the data, except those for the apo form, were indexed and integrated using the Mosflm and Imosflm packages [31] , and then scaled and merged according to Scala [32] . Statistics of data collection and data reduction are reported in Table 1 .
Structure solution and refinement
The structure solution of the apo and Y167F mutant forms of 17β-HSDcl have been reported previously [30] . Crystal structures of the other crystal forms were solved by Patterson search procedure using Phaser (holo form) and MOLREP (coumestrol ternary complex) software packages [32] . The refined apo structure was used as the search model. For all of the structures, the same refinement protocol was used. A first simulating annealing refinement cycle was performed, followed by positional restrained minimization and B-factor refinement, as implemented in the CNS software package [33] . Strict NCS (Non-Crystallographic Symmetry) restraints were initially applied when appropriate and then relaxed in the following refinement cycles. Cycles of model rebuilding with the program Coot [34] were then alternated with TLS (translation, liberation, screw-rotation) refinement, using the REFMAC software [32] . Medium-weighted NCS restraints were used only for the ternary complex structure throughout the refinement, leaving the substrate-binding loop (residues 200-230) free of NCS restraints. Water and ligands were introduced once the protein model could not be further improved and refined without NCS restraints. Ligand geometries and topologies for REFMAC were obtained by using the PRODRG web-server (http://davapc1.bioch.dundee.ac.uk/prodrg/).
All of the final models were subjected to a final geometry and refinement quality check using the following software packages: Procheck [32] , NQ-flipper webserver (https://flipper.services.came.sbg.ac.at/cgi-bin/flipper.php) and SFCheck [32] , and eventually re-refined according to their indications. The selected refinement parameters and quality indicators are reported in Table 1 . The PDB codes of the structures deposited are 3IS3 (apo), 3ITD (Y167F mutant), 3QWF (holoenzyme) and 3QWI (coumestrol-inhibited ternary complex).
RESULTS AND DISCUSSION

First turnover measurements reveal that coenzyme release is the rate-limiting step of the reaction
We have already provided evidence [17] [18] [19] 35] that the reaction between 17β-HSDcl follows a Theorell-Chance mechanism (see reactions 1 and 2) which presumes that the ternary EAB complex does not accumulate [25, 36] :
where E represents the enzyme, A, P, B and Q are NADPH and NADP + , and the oxidized and reduced substrates respectively. The linear dependence of the plots (see Supplementary Figures S2A and S2B, lower panels, at http://www.BiochemJ. org/bj/441/bj4410151add.htm) showing the initial rates against steroid concentration clearly pinpoints to the lack of an EAB complex accumulation. On the other hand, the dependence of the initial rates on coenzyme concentration, inferred from progress curves within each of the first seven panels in Supplementary Figures S2(A) and S3(B), would result in plots with curves with a trend parallel to the x-axis. Therefore, even at the lowest coenzyme concentration used (20 μM), the enzyme is saturated with the coenzyme. Overall, these findings corroborate the good affinity of 17β-HSDcl for either the reduced or oxidized form of the coenzyme.
To obtain direct experimental evidence for the rate-limiting step in the enzymatic reaction of 17β-HSDcl, we measured the initial rates of the reaction using a stopped-flow apparatus. This experiment recorded the changes in the redox state of the coenzyme when the reaction was started by the addition of the steroid substrate to the solution of the enzyme-coenzyme complex under saturating conditions. If the concentration of the initial enzyme-coenzyme complex is within a suitable concentration range for the determination method, the rate-limiting step of the complete reaction dictates the shape of the progress curve measured. The concave downwards curve obtained with a sloped asymptote, as clearly seen in Figure 1 (B), reveals that the *Calculated with 10 % of the data excluded from the structure refinement. †Calculated with 5 % of the data excluded from the structure refinement Table 2 Rate constants for the interconversion of 4-oestrene-17β-ol-3-one into 4-oestrene-3,17-dione by 17β-HSDcl in the presence of NADP + or NADPH, according to a Theorell-Chance reaction mechanism
i ). I(h,i) is the intensity of the ith measurement of the reflection h, and <I(h)> is the mean value over all i observations. R
In the evaluation from first turnover measurement, the overall equilibrium constant (
) was set to 0.4 and the second-order rate constants for the binding of the coenzymes were set as determined previously [35] . The remaining three fitted parameters are given with their standard errors.
Kinetic parameter
Data from [35] First turnover measurement exchange of a new coenzyme molecule after the first conversion is the slowest event during the reaction. The data from the first turnover measurements were processed in a combined analysis using some of our previously published values for the model characteristic rates and dissociation constants. The values from [35] are listed along with the updated ones in Table 2 . For the evaluation, we used a numerical integration solver [37] , which has recently been implemented as a web-server application [38] .
The substrate-binding loop accounts for a large part of the 17β-HSDcl conformational variability
The crystal structures of 17β-HSDcl in its apo form as well as bound to NADPH and the coumestrol-inhibited ternary complex have been determined. The protein backbone encompassing residues 14-270 of 17β-HSDcl was continuously traced inside the electron density in all of the cases considered here, with an expected poorer 2F o − F c map for the flexible substrate-binding loop in the holo form and in the ternary complexes. The Nterminal residues showed poorer electron density, and for all of the structures determined, the chain backbone could not be traced for the first nine residues. The residues from 10 to 14 show structural plasticity, and they can assume two possible conformations. All of the refined structures showed overall good final geometries, as indicated by the quality descriptors reported in Table 1 .
The 17β-HSDcl structure has a central seven-stranded parallel β-sheet that is flanked by six α-helices, three on each side ( Figure 2A) ; there are two more small α-helices, α1 and α2, located in the substrate-binding loop, which is a helixloop-helix domain that acts as a flexible lid that covers the active site. In all of the crystal structures described in the present paper, the general fold and shape is conserved with approximate overall monomer dimensions of 55 Å × 48 Å × 46 Å. The RMSDs (root mean square deviations) calculated with ProFit (http://www.bioinf.org.uk/software/profit/) on 254 Cα atoms between the apo form and the holo monomers span between 0.6 and 0.9 Å, depending on the subunit considered: values of 0.65 Å were obtained when comparing the apo form and the ternary complex. The omission of 31 residues spanning the substrate-binding loop (residues 200-230) in the structure comparisons almost halved the RMSDs between the apo and the holo forms, and lowered the RMSDs by ∼30 % for the comparison of the apo form and the ternary complex. Taken together, these data clearly show an almost identical structure, although they also reveal that the substrate-binding loop accounts for a large part of the conformational variability of 17β-HSDcl.
The interactions between monomers through the Q-interface are tighter than those through the P-interface
Crystallographic analysis showed that 17β-HSDcl is organized as a homotetramer, independent of the crystal form considered, although 17β-HSDcl is a homodimer in its functionally active form [13, 15] . This is not unusual, as SDR enzymes often show a common crystallographic tetrameric arrangement despite homodimeric functional forms. SDR crystallographic tetramers show a 222 symmetry with P, Q and R dyads, according to the SDR crystal structures convention [11] ( Figure 2B and see Supplementary Figure S3 at http://www.BiochemJ. org/bj/441/bj4410151add.htm). The Q axis associates monomers through αE and αF helix interactions (Q-interface), and the P axis involves the C-terminal residues, including αG, βG and their connecting loop, and N-terminal residues (P-interface). Subunit interactions through the R axis, which is orthogonal to both the P and Q axes, are generally scarce. It was shown that the Q-interface is responsible for the dimerization of 17β-HSDcl in solution [39, 40] and that the four-helix bundle formed upon dimerization is probably responsible for maintaining the activesite residues in the correct, catalytically active, conformation. Our crystallographic study confirms that the catalytic residues, Tyr 167 and Lys 171 , are part of helix αF that is involved in homodimer formation. However, the total interface area of the Q-interface of the holo crystal structure (3602 Å 2 ) is not much greater than that of the P-interface (3356 Å 2 ), and both of these are well above the 1600 Å 2 indicated by Janin and Chothia [41] as the minimum value for potential functionally relevant protein interfaces. Moreover, interface structural dissection showed that, despite the Q-interface generally having slightly better parameters than the P-interface for functionally relevant surface interactions, these two interfaces are not dissimilar when considering their general features (see Supplementary Table S1 at http://www.BiochemJ.org/bj/441/bj4410151add.htm). Nonetheless, the monomers interacting through the Q-interface are in tighter contact than those bound through the P-interface. The gap volume between the interfacing surfaces is much less for the Q-interface (2261 Å 3 ) than for the P-interface (5046 Å 3 ) which is in agreement with the lower number of water molecules and the protein-water interactions characterizing the former. Furthermore, a higher percentage of atoms, tightly interacting, participate to the Q-interface. Together, all of these data agree with the observed functional relevance of the Q-interface.
It is interesting to note that the 17β-HSDcl homologue, 3HNR from M. grisea (3HNRmg), shows different oligomerization patterns in solution [39, 40] , but not in the crystal. 3HNRmg in solution is functional as a tetramer, involving both P-and Qinterfaces. These data raise the question of why do the structurally similar 17β-HSDcl and 3HNRmg adopt different oligomerization states? A comparison of the 17β-HSDcl and 3HNRmg (PDB code 1G0O) [42] P-interfaces shows a remarkable sequence identity and structural similarity in the C-terminal residues: a large and deeply buried Trp 257 (17β-HSDcl numbering), Phe 261 stacking with the same residue from a neighbouring monomer, and a salt bridge between Asp 266 and Lys 261 . A further inspection of the 3HNRmg P-interface shows instead a marked difference in the N-terminal region that extensively participates in the P-interface interactions. Such extended interactions are almost absent from 17β-HSDcl. The involvement of the N-terminal residues in the 3HNRmg P-interface results in a much larger interface area (4510 Å 2 ) when compared with its equivalent interface in 17β-HSDcl, and is probably responsible for the energetically favoured shift of the oligomerization. Interestingly, the Q-interface in 3HNRmg does not substantially differ from its equivalent in 17β-HSDcl (3450 Å 2 for 3HNRmg), probably playing a similar role as hypothesized for fungal HSD [39] .
NADPH forms a complex interaction network
In the apo structure, the coenzyme-binding site is filled by a network of water molecules, with the entire cavity encompassing the adenine site and the catalytic Tyr 167 . In the coenzyme-bound binary complex, a well-defined electron density was observed ( Figure 2C ) where a NADPH molecule could be easily fitted and refined. NADPH in holo 17β-HSDcl adopts an extended shape, with the nicotinamide ring in the syn conformation, in agreement with the stereochemistry of the B-face 4-pro-S hydride transfer in catalysis. Upon binding, the NADPH coenzyme establishes several polar and ionic interactions with the 17β-HSDcl protein, as shown in Figure 3(A) . The adenine ring is lodged inside a protein cleft that is partially exposed to the solvent. The phosphate group in position 2 of the adenine ribose forms several hydrogen bonds with protein residues and water molecules in analogy to what has been observed for Arg 28 , the basic residue that is responsible for the NADP(H) selectivity of 17β-HSDcl. Adenine ribose assumes a C2 -endo conformation and interacts through its 3 -hydroxy group with Gly 25 , one of the conserved residues of the coenzyme-binding site in the SDR superfamily. The nicotinamide ribose also adopts a C2 -endo conformation and forms essential hydrogen bonds through its hydroxy groups, with the side chains of the catalytic Tyr 167 and Lys 171 . The nicotinamide ring is buried inside the catalytic pocket.
As well as these polar interactions, the NADPH coenzyme is involved in several hydrophobic interactions. The nicotinamide ring is 'sandwiched' between the side chain of Met 204 and Pro 197 , which is one of the most conserved residues in the SDR enzymes.
The active site is hosted in a hydrophobic pocket and it is covered by a flexible lid
The active site is located at the bottom of a mostly hydrophobic pocket, with Tyr 167 and Lys 171 interacting with NADPH, and Ser 153 situated in a turn between βE and αF ( Figure 3B ). The substratebinding loop partially shields the active site from the bulk solvent. No significant positional differences are observed in the catalytic triad among the different crystallographic structures of the present study. Also, the mutation of Tyr 167 to phenylalanine does not have any appreciable effect on the overall geometry of the active site as witnessed by the Y167F mutant crystal structure.
The catalytic pocket encompasses a free volume of ∼320 Å 3 , and it is filled in the apo, Y167F and holo forms by glycerol molecules and PEG fragments both present in the crystallization cocktail. In the coumestrol-inhibited ternary complex, two ethylene glycol molecules are situated at the entrance of the cavity. Overall, the catalytic pocket shows a clear affinity for hydroxylated organic molecules, which occupy the putative substrate site in the apo and the holo forms.
In a previous study based on kinetic and thermodynamic data [35] , it was hypothesized that Tyr 212 and His 164 control the open/closed conformation of 17β-HSDcl. In the present study, our crystallographic data show that Tyr 212 that is located at the C-terminus of helix α1, belonging to the substrate-binding loop, is indirectly linked through a water bridge to His 164 , which is a residue just before the N-terminal of helix αF ( Figure 3D ). This interaction, involving Tyr 212 OH and His 164 Nε2, is present in both the apo and holo forms, but not in the ternary complex where it is replaced by a direct, but geometrically less favoured, hydrogen bond between the same atoms. These findings are somewhat surprising, considering that the holo and apo forms are the most conformationally distant states as discussed in below.
Analysis of the structural determinants responsible for the different substrate specificities of 17β-HSDcl and fungal 3HNRs was reported in a previous study [14, 21] . Indeed, the superimposition of the coumestrol-inhibited 17β-HSDcl crystal structure with that of a ternary complex of 3HNRmg inhibited by pyroquilon shows that coumestrol would clash with Trp 243 of 3HNRmg. In 17β-HSDcl, the back side of the inhibitor-binding site is probably defined by Met 227 , which leaves more space for the correct steroid accommodation.
Crystal structures of 17β-HSDcl are snapshots along the reaction pathway
A general mechanism for carbonyl reduction with the SDR enzymes [43] involves proton transfer from the catalytic tyrosine residue to the carbonyl oxygen, coupled with hydride transfer from the nicotinamide ring to the C(sp 2 ) of the carbonyl group. For the oxidation case, the reverse hydride/proton transfer occurs. The catalytic lysine residue should lower the pK a of the tyrosine residue, which makes the proton transfer easier and the catalytic serine residue should stabilize the reaction intermediates at the reduction centre. This general mechanism requires a tyrosine residue as a proton/donor acceptor, and proton shuttle to the bulk solvent to re-establish the catalytically competent triad. It has been hypothesized [44] that a buried water molecule and a conserved asparagine residue (Asn 127 in 17β-HSDcl) proximal to the catalytic lysine residue take part in the proton shuttling from the catalytic lysine residue to the bulk solvent, as observed in apo alcohol dehydrogenase from Drosophila lebanonensis [36] . A proton-relay system has also been suggested for 3HNRmg, where a structurally conserved buried water can bridge the catalytic lysine residue and the conserved asparagine residue [45] . In the present study, we have produced snapshots of 17β-HSDcl in three different states of the enzyme action according to the proposed reaction mechanism. The apoenzyme crystal structure shows a catalytic triad that is well exposed to the solvent molecules that in turn populate both the active site and the coenzyme-binding channel. The holoenzyme and the inhibited ternary complex structures show a quite different water arrangement, with fewer solvent molecules in the active site, and with Lys 171 having no contacts with any solvent molecules. Only two water molecules are conserved in all but one of the monomers of the holoenzyme structure: the water molecule that bridges His 164 and at least two conserved water molecules. The two individual water molecules found in the coumestrol crystal structure suggest the involvement of a solvent water in the catalytic proton/hydride-transfer step. However, the substrate would be closer to Tyr 167 and to the coenzyme, leaving no room for a nearby solvent molecule ( Figure 3B) . Thus it appears that the proton shuttling follows the product release after the reduction or oxidation step, as previously proposed for Drosophila alcohol dehydrogenase [43] . Moreover the progressive water depletion that occurs as the reaction progresses could affect the intrinsic pK a of Tyr 167 as a consequence of the increasing shielding of the catalytic centre from the bulk solvent. Our hypothesis does not contradict the reaction mechanisms described in reactions 1 and 2. A labile enzyme-NADP(H)-substrate complex is rapidly converted into products in a mechanism that is supported by the stopped-flow experiments described in the present paper, which agrees well with fast proton shuttling following the oxidoreduction step.
The driving-force for coumestrol binding is π -π interactions between Tyr 212 and the coumarin moiety
The crystal structure of the ternary complex inhibited by coumestrol was also determined. The 2F o − F c and F o − F c omit maps showed coumestrol to be present in three out of four possible catalytic pockets ( Figure 2D ). Its correct position and orientation in the catalytic pockets was established after exploring different orientations of the rigid and asymmetric coumestrol moiety, followed by crystallographic refinement. The model of the present paper was the best that would fit the 2F o − F c map together with the lowest F o − F c peak level. The crystallographic analysis shows that the coumestrol occupancy in monomer C was too low to be included in the final crystallographic model. Moreover, the electron-density maps and the refined B-factors of the coumestrol suggested an uneven occupation of the other three sites that was not refined nor investigated further. Unequal occupation of the monomers' active sites is due to packing effects, which differently hinder the accessibility of the diverse active sites as well as the mobility of the different substrate-binding loops, thus modulating the effective affinity of the different active sites. Coumestrol occupies the putative steroid-binding site inside the catalytic pocket, thus confirming previous studies [27] . This inhibitor shows an interaction pattern common with the enzyme, which involves Tyr 212 and Asn 154 ( Figure 3B ). The driving force for binding appears to be a π-π stacking between the aromatic side chain of Tyr 212 and the aromatic coumarin moiety (see Table 3 for selected distance values). Coumestrol is 'sandwiched' between Tyr 212 and Gly 199 with a water bridging its carbonyl to Gly 199 peptide N, and a hydrogen bond between the same carbonyl and Asn 154 Nδ2. Additionally, there is also stacking between the hydroxy group in position 3 and the carbonyl of the carboxyamide group of NADPH, resulting in an antiparallel dipole orientation. These interactions appear to be more effective within subunit A, with coumestrol being closer to the nicotinamide moiety. Two hydrogen bonds with two crystallization waters are also observed in all of the coumestrol-occupied monomers. Finally, there is a weak interaction between hydroxy group 3 and Sδ of Met 204 , more relevant in monomer A, with coumestrol pushed slightly towards the coenzyme.
If such an interaction pattern is conserved for steroid substrates, an explanation for their weak binding might arise from steroids not being planar molecules and lacking an extended aromatic system. The relatively strong π-π stacking that is observed between coumestrol and the Tyr 212 side chain is not possible with steroids, which instead might establish weaker hydrophobic interactions. Moreover, all of the steroids tested as substrates of 17β-HSDcl lack hydrogen-bond donor/acceptor-interacting abilities with Asn 154 , as seen in our inhibited ternary complex. This structural data conforms well with the kinetics results of the weak binding of steroids to the holoenzyme. Indeed, we did not observe bound steroids in any of our attempts to determine the crystal structure of the product/substrate-bound ternary complex, not even when we used the inactive Y167F mutant.
Our structural data agree well with the two kinetics experiments that pinpointed the dissociation of the coenzyme as the rate-determining step of the entire catalytic cycle. First, the direct determination of high coenzyme affinities by native tryptophan fluorescence suggests that the coenzyme dissociation rates are in the range of the enzyme turnover number [35] . Secondly, the concave downwards curve of the initial turnover recording obtained by the rapid kinetics experiment reveals that the proton and hydride transfers during the reaction occur faster than the subsequent exchange of the used coenzyme molecule by a new one.
The binding of NADPH affects the conformation of the substrate-binding loop
The substrate-binding loop, which can be roughly defined as a domain that includes residues from 199 to 238, is organized into two almost orthogonal helices that also include several turns and coil subregions. This loop shows an intrinsic flexibility, witnessed by a poor-quality electron-density map and large B-factors. The NADPH coenzyme binding induces a conformational transition in the α1 helical region. Two short 3 10 (Figures 3C and 3D) .
The binding of the inhibitor does have smaller and local effects on the loop conformation: Tyr 212 is pushed towards the catalytic site by ∼1 Å with rotation of the aromatic ring of ∼40
• ( Figure 3D) . In monomer C, where the inhibitor is absent, the position and orientation of Tyr 212 is substantially coincident with the position assumed in the inhibitor-free holo form.
Structural rearrangements of the substrate-binding loop upon NADPH coenzyme binding can be globally depicted as the movement of a rigid domain. Following the DynDom approach [46] , comparisons of the apo and the holo forms revealed a hinge-bending motion of a rigid region that include residues 201-227, with the hinges defined by residues 200-204 and 227-228 respectively, with an average rotation of the rigid region of ∼18
• . Similar conclusions can be reached by inspecting the error-scaled DDM (distance-difference matrix) calculated with the ESCET program [47] . Regions that are involved in the conformational changes are identified comparing the apo and holo structures, by calculating the differences between equivalent interatomic distances in the two models (see Supplementary Figure  S4 at http://www.BiochemJ.org/bj/441/bj4410151add.htm). This analysis shows that the regions that include residues 27-29, 49-55 and 201-227 experience Cα movements that are greater than 1 Å.
The DynDom analysis when comparing the holo form and the coumestrol ternary complex shows no rigid domain movement. Accordingly, DDM calculated on the holo form and the ternary complex (see Supplementary Figures S4C and S4D) , show that the Cα displacement affects only the central part of the substratebinding loop. These findings support our hypothesis of minor and local structural rearrangements upon inhibitor binding.
The comparisons of the apo and holo enzyme structures show remarkable structural changes, and it is realistic that a large activation energy is required for coenzyme dissociation. On the other hand, dissociation of the enzyme-NADPH-substrate complex and the release of the product implicate a minor reorganization of the enzymatic system, as seen by our crystal structures and kinetics data, presumably with a lower activation barrier. A substrate-binding loop motion has previously been postulated in the SDR enzyme mechanism [11] and this has been mainly associated with a 'closure' of the loop on to the catalytic pocket to protect the reaction centre from the bulk solvent [43] . The present study depicts more subtle conformational differences in this loop in 17β-HSDcl. NADPH binding implicates a 'closure' movement of the outer part of the loop, whereas the inner part assumes a more open conformation. This is plausible, as residues 210-220 act as a flexible flap that can control the entrance of the substrate to the active site. The comparison of the holoenzyme with the ternary complex shows that it is only the central part of the loop that experiences this shrinking movement, thus closing the access to the active site ( Figure 3D , and see Supplementary Figure S4C ). Therefore a more complex situation occurs along the reaction pathway, as a likely consequence of the involvement of Tyr 212 in the active site. A previous kinetics study established that the mutation of Tyr 212 to alanine slightly decreased the interconversion rates between substrates and products [35] . Indeed, our structural data show that the Tyr 212 position is shifted inwards and rotated around Cβ-Cγ upon substrate/inhibitor binding, to accommodate the ligand. This observation suggests that, in 17β-HSDcl, the dynamics of the substrate-binding loop are not just related to a solvent-shielding role, but also to a specific and functionally relevant action.
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Figure S3 Quaternary structure
Solvent-accessible surface of the crystallographic 17β-HSDcl tetramer together with the P and Q reference two-fold axes. Interacting surface residues are coloured according to their different localizations (P-interface, blue; Q-interface, red).
Figure S4 Distance-difference matrices
Error-weighted DDMs calculated on Cα for different 17β-HSDcl forms. All of the DDMs were calculated for the same region of residues 15-270. Secondary-structure elements are indicated (bottom panels) by black (strand) or white (helix) rectangles respectively. White background indicates rigidly moving regions, as determined by the ESCET program. For every matrix, the upper triangle reports the absolute difference in Å. The blue and red colours indicate a shortening or lengthening of the distances respectively. The lower triangles describe the differences in distances in terms of σ with respect to the positional uncertainties (the same colour coding as for the absolute differences). 
